HIV vaccine efficacy trials: Towards the future of HIV prevention

被引：16
|
作者：
Kim, Denny [1 ]
Elizaga, Marnie [1 ]
Duerr, Ann [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98109 USA
来源：
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2007年 / 21卷 / 01期
关键词：
D O I：
10.1016/j.idc.2007.01.006
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Past efficacy trials of HIV vaccines have attempted to generate neutralizing antibodies. With the failure of these trials to demonstrate protection, the focus for HIV vaccine development has shifted to inducing a cytotoxic T-lymphocyte response (CTL). A CTL response is not expected to produce sterilizing immunity but may delay progression to AIDS or reduce the transmission of HIV Adenovirus vector-based regimens that induce CTLs are currently in efficacy trial testing. These efficacy trials are using surrogate end points in an innovative Phase 2B trial design.
引用
收藏
页码：201 / +
页数：18
相关论文
共 50 条
  • [1] Modeling HIV vaccine trials of the future
    Gilbert, Peter B.
    Huang, Ying
    Janes, Holly E.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2016, 11 (06) : 620 - 627
  • [2] Preparation for HIV vaccine efficacy trials
    Hoff, R
    Lawrence, DN
    [J]. DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 155 - 160
  • [3] PREPARATIONS FOR HIV VACCINE EFFICACY TRIALS
    VERMUND, SH
    LAWRENCE, DN
    FISCHER, RD
    FAST, P
    RIDA, WN
    SCHRAGER, LK
    BRADAC, J
    SHEON, AR
    CORDELL, JR
    DUNBAR, S
    BARKER, LF
    HOFF, R
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 746 - 746
  • [4] THE ROLE OF PREVENTION RESEARCH IN HIV VACCINE TRIALS
    VERMUND, SH
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S303 - S305
  • [5] HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials
    Phanuphak, Nittaya
    Lo, Ying-Ru
    Shao, Yiming
    Solomon, Sunil Suhas
    O'Connell, Robert J.
    Tovanabutra, Sodsai
    Chang, David
    Kim, Jerome H.
    Excler, Jean Louis
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (11) : 1060 - 1076
  • [6] Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States
    Koblin, BA
    Heagerty, P
    Sheon, A
    Buchbinder, S
    Celum, C
    Douglas, JM
    Gross, M
    Marmor, M
    Mayer, K
    Metzger, D
    Seage, G
    [J]. AIDS, 1998, 12 (07) : 785 - 793
  • [7] INTERNATIONAL DISUNITY ON HIV VACCINE EFFICACY TRIALS
    COTTON, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (14): : 1090 - 1091
  • [8] Control groups for HIV prevention efficacy trials: what does the future hold?
    Janes, Holly
    Buchbinder, Susan
    [J]. CURRENT OPINION IN HIV AND AIDS, 2023, 18 (06) : 349 - 356
  • [9] PREPARATIONS FOR HIV VACCINE EFFICACY TRIALS - VACCINE SELECTION GUIDELINES
    BARKER, LF
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S295 - S296
  • [10] Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities
    Janes, Holly
    Zhu, Yifan
    Brown, Elizabeth R.
    [J]. STATISTICS IN BIOSCIENCES, 2020, 12 (03) : 468 - 494
12345